Deutsche Bank’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Deutsche Bank’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-137	Closed	-$6K	–	4707
2020 Q4	$6K	Buy	+137	New	+$6.13K	﹤0.01%	4346
2020 Q3	–	Hold	0	–	–	–	4474
2020 Q2	–	Hold	0	–	–	–	4515
2020 Q1	–	Sell	-116	Closed	-$15K	–	4953
2019 Q4	$15K	Buy	+116	New	+$14.1K	﹤0.01%	4391
2019 Q3	–	Sell	-40	Closed	-$5K	–	5368
2019 Q2	$5K	Buy	+40	New	+$7.02K	﹤0.01%	5100

Other funds holding ORTX

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deutsche Bank's ORTX Position: Q1 2021 in Review

Deutsche Bank sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2021, closing a stake of 137 shares — an estimated $6K sold.

Deutsche Bank first reported a position in ORTX in Q2 2019 and held it in 3 quarters. The position peaked at $15K in Q4 2019. 83 funds tracked by Wall St. Rank hold ORTX as of Q1 2021.

Deutsche Bank reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Deutsche Bank sold 137 Orchard Therapeutics plc American Depositary Shares shares in Q1 2021, an estimated $6K.
Deutsche Bank first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and held it in 3 quarters.
Deutsche Bank's Orchard Therapeutics plc American Depositary Shares position peaked at $15K in Q4 2019.
83 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2021.

Based on Deutsche Bank's 13F filing for Q1 2021, filed 13 May 2021.